PRS
ENTA icon

Pinkerton Retirement Specialists’s Enanta Pharmaceuticals ENTA Stock Holding History

Pinkerton Retirement Specialists’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-528
Closed -$12K – 622
2016
Q2 		$12K Buy
+528
New +$13.8K 0.01% 371

Other funds holding ENTA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Pinkerton Retirement Specialists's ENTA Position: Q3 2016 in Review

Pinkerton Retirement Specialists sold out of Enanta Pharmaceuticals (ENTA) in Q3 2016, closing a stake of 528 shares — an estimated $12K sold.

Pinkerton Retirement Specialists first reported a position in ENTA in Q2 2016 and held it in 1 quarter. The position peaked at $12K in Q2 2016. 136 funds tracked by Wall St. Rank hold ENTA as of Q3 2016.

  • Pinkerton Retirement Specialists reported no remaining Enanta Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Pinkerton Retirement Specialists sold 528 Enanta Pharmaceuticals shares in Q3 2016, an estimated $12K.
  • Pinkerton Retirement Specialists first reported a position in Enanta Pharmaceuticals in Q2 2016 and held it in 1 quarter.
  • Pinkerton Retirement Specialists's Enanta Pharmaceuticals position peaked at $12K in Q2 2016.
  • 136 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2016.

Based on Pinkerton Retirement Specialists's 13F filing for Q3 2016, filed 14 Nov 2016.